Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics
PRNewsWire
·
2026-05-18
·
via The Tech Buzz - Press Releases
Strengthens Neurocrine's rare disease portfolio with VYKAT™ XR, the first and only approved treatment for hyp…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。